These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 34576214)

  • 1. Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways.
    Sevilla LM; Jiménez-Panizo A; Alegre-Martí A; Estébanez-Perpiñá E; Caelles C; Pérez P
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homeostatic Regulation of Glucocorticoid Receptor Activity by Hypoxia-Inducible Factor 1: From Physiology to Clinic.
    Marchi D; van Eeden FJM
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
    Sevilla LM; Pérez P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of Glucocorticoid Signaling.
    Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
    Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Glucocorticoid Resistance Due to Homologous Glucocorticoid Receptor Downregulation: A Modern Look at an Age-Old Problem.
    Spies LL; Verhoog NJD; Louw A
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.
    Miller AL; Webb MS; Copik AJ; Wang Y; Johnson BH; Kumar R; Thompson EB
    Mol Endocrinol; 2005 Jun; 19(6):1569-83. PubMed ID: 15817653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways.
    Ayroldi E; Cannarile L; Migliorati G; Nocentini G; Delfino DV; Riccardi C
    FASEB J; 2012 Dec; 26(12):4805-20. PubMed ID: 22954589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts in glucocorticoid resistance.
    Yang N; Ray DW; Matthews LC
    Steroids; 2012 Sep; 77(11):1041-9. PubMed ID: 22728894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance.
    Ramamoorthy S; Cidlowski JA
    Endocr Dev; 2013; 24():41-56. PubMed ID: 23392094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.
    De Iudicibus S; Franca R; Martelossi S; Ventura A; Decorti G
    World J Gastroenterol; 2011 Mar; 17(9):1095-108. PubMed ID: 21448414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.
    Beck IM; Vanden Berghe W; Vermeulen L; Yamamoto KR; Haegeman G; De Bosscher K
    Endocr Rev; 2009 Dec; 30(7):830-82. PubMed ID: 19890091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease.
    Galliher-Beckley AJ; Cidlowski JA
    IUBMB Life; 2009 Oct; 61(10):979-86. PubMed ID: 19787703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis.
    Koenen M; Culemann S; Vettorazzi S; Caratti G; Frappart L; Baum W; Krönke G; Baschant U; Tuckermann JP
    Ann Rheum Dis; 2018 Nov; 77(11):1610-1618. PubMed ID: 29997111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cholesterol selectively regulates glucocorticoid sensitivity through activation of JNK.
    Yang N; Caratti G; Ince LM; Poolman TM; Trebble PJ; Holt CM; Ray DW; Matthews LC
    J Endocrinol; 2014 Nov; 223(2):155-66. PubMed ID: 25161081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A General Introduction to Glucocorticoid Biology.
    Timmermans S; Souffriau J; Libert C
    Front Immunol; 2019; 10():1545. PubMed ID: 31333672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
    Vandevyver S; Dejager L; Tuckermann J; Libert C
    Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
    Hapgood JP; Avenant C; Moliki JM
    Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptor signaling in the eye.
    Sulaiman RS; Kadmiel M; Cidlowski JA
    Steroids; 2018 May; 133():60-66. PubMed ID: 29129720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-genomic effect of glucocorticoids on cardiovascular system.
    Lee SR; Kim HK; Youm JB; Dizon LA; Song IS; Jeong SH; Seo DY; Ko KS; Rhee BD; Kim N; Han J
    Pflugers Arch; 2012 Dec; 464(6):549-59. PubMed ID: 23001133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
    He L; Li D; Hou KZ; Liu YP
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.